Quest Diagnostics Price to Book Ratio 2010-2024 | DGX

Historical price to book ratio values for Quest Diagnostics (DGX) over the last 10 years. The current price to book ratio for Quest Diagnostics as of January 31, 2025 is 2.54.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Quest Diagnostics Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-01-31 163.10 2.67
2024-09-30 154.48 $61.08 2.53
2024-06-30 135.47 $59.96 2.26
2024-03-31 130.99 $58.28 2.25
2023-12-31 134.97 $57.14 2.36
2023-09-30 118.60 $57.71 2.06
2023-06-30 136.11 $56.13 2.42
2023-03-31 136.32 $54.36 2.51
2022-12-31 150.06 $53.42 2.81
2022-09-30 117.07 $55.02 2.13
2022-06-30 126.27 $55.13 2.29
2022-03-31 129.32 $54.83 2.36
2021-12-31 162.75 $54.48 2.99
2021-09-30 136.09 $52.29 2.60
2021-06-30 123.03 $48.69 2.53
2021-03-31 119.07 $51.83 2.30
2020-12-31 110.07 $51.20 2.15
2020-09-30 105.24 $47.75 2.20
2020-06-30 104.25 $43.89 2.38
2020-03-31 72.94 $42.56 1.71
2019-12-31 96.52 $42.76 2.26
2019-09-30 96.25 $41.88 2.30
2019-06-30 91.08 $40.81 2.23
2019-03-31 79.98 $39.86 2.01
2018-12-31 73.60 $39.01 1.89
2018-09-30 94.92 $39.45 2.41
2018-06-30 96.27 $38.70 2.49
2018-03-31 87.38 $37.25 2.35
2017-12-31 85.42 $36.70 2.33
2017-09-30 80.83 $35.50 2.28
2017-06-30 95.55 $34.80 2.75
2017-03-31 84.02 $34.04 2.47
2016-12-31 78.25 $34.01 2.30
2016-09-30 72.06 $33.77 2.13
2016-06-30 68.66 $32.87 2.09
2016-03-31 59.93 $33.09 1.81
2015-12-31 59.33 $32.96 1.80
2015-09-30 50.96 $32.09 1.59
2015-06-30 59.80 $30.17 1.98
2015-03-31 63.05 $29.66 2.13
2014-12-31 54.76 $30.07 1.82
2014-09-30 49.28 $29.03 1.70
2014-06-30 47.40 $28.60 1.66
2014-03-31 46.52 $27.92 1.67
2013-12-31 42.76 $27.59 1.55
2013-09-30 49.35 $26.63 1.85
2013-06-30 48.19 $25.94 1.86
2013-03-31 44.65 $26.77 1.67
2012-12-31 45.61 $26.49 1.72
2012-09-30 49.65 $26.45 1.88
2012-06-30 46.76 $25.40 1.84
2012-03-31 47.60 $24.58 1.94
2011-12-31 44.94 $23.60 1.90
2011-09-30 38.12 $22.52 1.69
2011-06-30 45.64 $21.81 2.09
2011-03-31 44.42 $20.61 2.16
2010-12-31 41.46 $23.75 1.75
2010-09-30 38.77 $22.78 1.70
2010-06-30 38.08 $22.28 1.71
2010-03-31 44.53 $21.85 2.04
2009-12-31 46.05 $21.89 2.10
2009-09-30 39.80 $21.31 1.87
2009-06-30 42.88 $20.28 2.11
2009-03-31 36.00 $19.06 1.89
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.349B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.703B 0.00
DaVita (DVA) United States $14.249B 18.43
Encompass Health (EHC) United States $9.629B 22.70
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
RadNet (RDNT) United States $4.972B 110.11
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00